The chemical class known as NAT-1 inhibitors encompasses a diverse group of organic compounds that share a common functional characteristic: their ability to impede the activity of the N-acetyltransferase 1 (NAT-1) enzyme. This enzyme is involved in the acetylation process of various substrates, including arylamines and hydrazines. The inhibition of NAT-1 by this class of compounds arises from their structural and chemical attributes that allow them to interact with the enzyme's active site. These inhibitors competitively or non-competitively bind to the active site, thereby obstructing the enzyme-substrate interaction necessary for the acetylation process. The chemical structures of NAT-1 inhibitors can vary significantly, as they encompass an array of compounds from a variety of different sources, including synthetic molecules and naturally occurring substances. Among the diverse classes of NAT-1 inhibitors are sulfonamides, PABA derivatives, flavonoids, and aromatic compounds such as isoniazid. These inhibitors often exhibit structural resemblances to the substrates of NAT-1, allowing them to bind to the enzyme's active site with varying affinities. The inhibition mechanism can be attributed to the disruption of substrate binding or the alteration of the enzyme's catalytic activity.
Researchers have sought to understand the intricate molecular interactions between NAT-1 inhibitors and the enzyme itself. Computational modeling and structural analyses have provided insights into the binding modes and binding energies of various inhibitors within the enzyme's active site. Such studies contribute to elucidating the structure-activity relationships that govern the effectiveness of these inhibitors. Further, investigating these inhibitors sheds light on the intricate mechanisms of enzyme-substrate interactions and catalysis, enhancing our broader understanding of enzymology and molecular biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoniazid | 54-85-3 | sc-205722 sc-205722A sc-205722B | 5 g 50 g 100 g | $26.00 $101.00 $146.00 | ||
Isoniazid targets NAT-1 by covalently binding to its active site, which disrupts the enzyme's ability to transfer acetyl groups from acetyl-CoA to its arylamine substrates, thus inhibiting NAT-1 mediated acetylation reactions. | ||||||
Sulfamethazine | 57-68-1 | sc-220159 | 25 g | $58.00 | 1 | |
Sulfamethazine acts as a competitive inhibitor of NAT-1, directly competing with arylamine substrates for binding to the active site of the enzyme, thereby reducing the enzyme's ability to acetylate its natural substrates. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin inhibits NAT-1 by binding to the enzyme's active site, possibly altering the enzyme's conformation and reducing its affinity for acetyl-CoA, thereby decreasing the enzyme's acetylation activity. | ||||||
Caffeic Acid | 331-39-5 | sc-200499 sc-200499A | 1 g 5 g | $32.00 $62.00 | 1 | |
Caffeic acid inhibits NAT-1 through a mechanism that likely involves the direct binding to the enzyme's active site, hindering the interaction between NAT-1 and its substrates and effectively reducing the enzyme's capacity for substrate acetylation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol inhibits NAT-1 activity by interacting with the enzyme's acetyl-CoA binding site, which prevents the formation of the enzyme-substrate complex necessary for the acetylation process, thereby decreasing NAT-1 activity. | ||||||
Sulindac | 38194-50-2 | sc-202823 sc-202823A sc-202823B | 1 g 5 g 10 g | $32.00 $86.00 $150.00 | 3 | |
Sulindac inhibits NAT-1 by possibly altering the enzyme's substrate specificity or by directly competing with substrates for binding sites, which affects the enzyme's normal acetylation reaction process. | ||||||
Ellagic Acid, Dihydrate | 476-66-4 | sc-202598 sc-202598A sc-202598B sc-202598C | 500 mg 5 g 25 g 100 g | $58.00 $95.00 $245.00 $727.00 | 8 | |
Ellagic acid is thought to inhibit NAT-1 by binding to the enzyme in a manner that interferes with substrate access to the active site, effectively reducing the enzyme's acetylation of arylamine and hydrazine substrates. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin inhibits NAT-1 by likely interfering with the binding of acetyl-CoA or the substrate to the enzyme, which impedes the enzyme's catalytic activity and results in decreased acetylation of its substrates. | ||||||